Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease... see more

TSX:SZLS - Post Discussion

View:
Post by Lalk3434 on Jun 03, 2021 4:41pm

PLEASE STOP

im a long time holder of szls .. But cmon...im reading this board and all the pumpers and bashers...but i would have never thought this is where we wud be sitting after Aristotle release...either trip is a moron or a criminal but something is goimg on...all these opertunities ...generating money...still glong down ...all those partnerships vanished i guess?
Comment by molotov420 on Jun 03, 2021 4:53pm
now the scotia lock up on buying shares is starting to make sense! Bottom line is the bullshyt has to stop eventually but where is the big question! F"in Rory man, took a huge L thanks to Tripp and his team and is taking it like a champ! I guess its a good sign he still hasnt sold.....but watta a guy lol
Comment by Liked2Think on Jun 03, 2021 5:19pm
Well this is getting to the point of insanity right now. Either the company is toast or its just been shorted like mad and it could be shorted by someone with big pockets for all I know.  Our one analyst might be pi$$ed and figured this was the way to make money.  Seems strange but you cant trust the hedge fund people anymore.  Not that you ever could. Ive had a few more pay ...more  
Comment by frewil11 on Jun 03, 2021 8:47pm
People still thinking this is trading where it is because of shorts or some other excuse , nope sorry its the poor management not getting this out to market and investors knowing it might not.
Comment by jp1989 on Jun 03, 2021 8:55pm
market capitalization 30 million and I estimate income at minimum 10 million 2021 we are underestimated. when everything goes wrong, go back to the basics
Comment by Mykndrsn on Jun 03, 2021 9:04pm
The market hates uncertainty. Nothing more certain than revenues and profits. The potential of Aristotle has been massively inc
Comment by Mykndrsn on Jun 03, 2021 9:06pm
Sorry - increased by the inclusion of Avrt. $$$ coming soon. Investors just need to hang tight. 
Comment by Mermer2328 on Jun 04, 2021 8:05am
I agree with You... ut at some point potential needs to turn into profit. Tripp damaged the meaning of potential April 1st.Hoping for some meaningful NR,s
Comment by Mermer2328 on Jun 03, 2021 8:20pm
In my opinion Aristotle has never been released. Not one company , institution or anyone in the bio field of any significance has mentioned a single word about it. And I'm sorry ,Tripps words mean very little these days with his track record. Hopefully something news worthy besides Covid testing is around the corner
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities